<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="margin-left: 0.25in; width: 7.2in;font-family: 'Times New Roman',Times,serif">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>

<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 OR 15(d) of The Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date
of Report (Date of earliest event reported): April 20, 2009</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>KREIDO BIOFUELS, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
<TD width="32%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="32%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="32%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
<TD nowrap align="center" valign="top"><B>Nevada
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>333-130606
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>20-3240178</B></TD>
</TR>
<TR style="font-size: 1px">
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">(State or other jurisdiction<BR>
of incorporation)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(Commission File Number)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(IRS Employer Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
<TD width="48%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
<TD align="center" valign="top"><B>1070 Flynn Road<BR>
Camarillo, California
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>&nbsp;<BR>93012</B></TD>
</TR>
<TR style="font-size: 1px">
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">(Address of principal executive offices)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code: <B>(805) 987-8231</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Not applicable</B></DIV>

<DIV align="center" style="font-size: 10pt"><FONT style="border-top: 1px solid #000000">(Former name or former address, if changed since last report.)</FONT></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio --> </DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;1.02 Termination of Material Definitive Agreement.</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">On April&nbsp;20, 2009, Kreido Biofuels, Inc. (the &#147;Company&#148;) effected a Separation Agreement and
General Release dated as of April 15, 2009 with G.A. Ben Binninger, Chief Executive Officer of the Company, pursuant to which
his Employment Agreement dated December&nbsp;1, 2007 and his employment with the Company and its wholly
owned subsidiaries were voluntarily terminated. Under the Separation Agreement, the Company paid
Mr.&nbsp;Binninger $53,958 of a total $107,917 total severance pay as provided for in his Employment
Agreement. The remaining $53,959 of severance pay will be paid when and as Company cash assets
allow for such payment and in all events no later than March&nbsp;5, 2010. Also by the Separation
Agreement, Mr.&nbsp;Binninger and the Company released and discharged each other from all known and
contingent liabilities and obligation. The Company retired stock options held by Mr.&nbsp;Binninger for
nominal consideration. Mr.&nbsp;Binninger will continue to serve as a director of the Company.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The
Company and Acaso Investments, LLC are entering into an Agreement Re: Termination
of Lease pursuant to which the parties terminated the Company&#146;s Lease dated June&nbsp;22, 2007
respecting the entire premises at 1070 Flynn Road in Camarillo, California (the &#147;Flynn Road
Premises&#148;) effective as of March&nbsp;31, 2009. The Company will allow Acaso to apply the security
deposit to satisfy its March rent obligation and to retain certain office furniture and equipment
in consideration for a release of all future rental obligations. Asorco
will buy other office equipment for
$10,000.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">John Philpott, the continuing officer of the Company, has arranged with Acaso to maintain an office
at the Flynn Road Premises for himself and will use that office as the Company&#146;s headquarters at no
cost to the Company for the term of his Employment Agreement summarized in Item&nbsp;5.02 below.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers</B>
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">As discussed under Item&nbsp;1.02 above, as of April&nbsp;15, 2009, the Company effected a Separation
Agreement with G.A. Ben Binninger, Chief Executive Officer of the Company, pursuant to which his
Employment Agreement dated December&nbsp;1, 2007 and his employment with the Company and its wholly
owned subsidiaries were terminated.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">On April&nbsp;23, 2009, the Company elected John Philpott, Chief Financial Officer of the Company, as
the Chief Executive Officer of the Company. The Company and Mr.&nbsp;Philpott entered into an
Employment Agreement dated April&nbsp;23, 2009 that replaces the Employment Agreement between the
Company and Mr.&nbsp;Philpott dated April&nbsp;30, 2008 and which was scheduled to expire on April&nbsp;30, 2009.
Mr.&nbsp;Philpott will report to the Board of Directors of the Company. He will not be required to
dedicate his full time or attention to the business of the Company. Rather, his primary
responsibilities will be to attend to the sale of the remaining equipment and inventory owned by
the Company, evaluating acquisition and merger opportunities, and attending to the Company&#146;s
periodic reporting requirements. Mr.&nbsp;Philpott will provide his own office space, which shall serve
as the Company&#146;s headquarters. The Company will pay Mr.&nbsp;Philpott a salary of $5,000 per month.
Mr.&nbsp;Philpott will have the opportunity to earn a performance bonus of between $1,000 and $50,000
depending upon his achieving target performance goals to be
established by the Board of Directors. The Employment Agreement is scheduled to terminate on May
31, 2010. As an inducement for Mr.&nbsp;Philpott accepting the Chief Executive Officer position and
waiving his rights under his April&nbsp;30, 2008 Employment Agreement, the Company will pay Mr.&nbsp;Philpott
an inducement payment of $252,800, of which $126,400 is to be paid on or before April&nbsp;30, 2009 and
the balance will be paid in installments when and as the Company has cash resources available to
make payments and in all events on or before March&nbsp;5, 2010. The Company has also released its
rights to repurchase 75,000 shares of Company common stock previously issued to Mr.&nbsp;Philpott.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>
</DIV>



<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%">(d)&nbsp;Exhibits
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3">Exhibit</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Number</TD>
</TR>


<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px" align="justify">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px" align="justify">Separation Agreement dated as of April&nbsp;15, 2009 by and among Kreido Biofuels, Inc., Kreido Laboratories and G.A. Ben Binninger.</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px" align="justify">&nbsp;</DIV></TD>
</TR>

<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px" align="justify">Employment Agreement dated April&nbsp;23, 2009 by and among Kreido
Biofuels, Inc. Kreido Laboratories and John Philpott.</DIV></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><U><B>Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995</B></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">Information included in this Form 8-K may contain forward-looking statements within the meaning of
Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;) and Section&nbsp;21E of the
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). This information may involve
known and unknown risks, uncertainties and other factors which may cause the Company&#146;s actual
results, performance or achievements to be materially different from future results, performance or
achievements expressed or implied by any forward-looking statements. Forward-looking statements,
which involve assumptions and describe the Company&#146;s future plans, strategies and expectations, are
generally identifiable by use of the words &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expect,&#148; &#147;anticipate,&#148;
&#147;estimate,&#148; &#147;believe,&#148; &#147;intend&#148; or &#147;project&#148; or the negative of these words or other variations on
these words or comparable terminology. These forward-looking statements are based on assumptions
that may be incorrect, and there can be no assurance that any projections included in these
forward-looking statements will come to pass. The Company&#146;s actual results could differ materially
from those expressed or implied by the forward-looking statements as a result of various factors.
Except as required by applicable laws, the Company undertakes no obligation to update publicly any
forward-looking statements for any reason, even if new information becomes available or other
events occur in the future.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURES</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">Dated:  April 24, 2009      &nbsp;</TD>
    <TD colspan="3" align="left">KREIDO BIOFUELS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John Philpott
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John Philpott&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="0" align="left">Its: </TD>
    <TD colspan="0" align="left">Chief Executive Officer&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c84260e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 17293}]
{"company-data": {"conformed-name": "Kreido Biofuels, Inc.", "cik": "0001342219", "assigned-sic": "2860", "irs-number": "203240178", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-130606", "film-number": "09770674"}, "business-address": {"street1": "1140 AVENIDA ACASO", "city": "CAMARILLO", "state": "CA", "zip": "93012", "phone": "805-389-3499"}, "mail-address": {"street1": "1140 AVENIDA ACASO", "city": "CAMARILLO", "state": "CA", "zip": "93012"}, "former-company": {"former-conformed-name": "Gemwood Productions, Inc.", "date-changed": "20051024"}}
Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): April 20, 2009
KREIDO BIOFUELS, INC.
(Exact name of registrant as specified in its charter)
Nevada
333-130606
20-3240178
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1070 Flynn Road
Camarillo, California
93012
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code:
(805) 987-8231
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.02 Termination of Material Definitive Agreement.
On April 20, 2009, Kreido Biofuels, Inc. (the "Company") effected a Separation Agreement and
General Release dated as of April 15, 2009 with G.A. Ben Binninger, Chief Executive Officer of the Company, pursuant to which
his Employment Agreement dated December 1, 2007 and his employment with the Company and its wholly
owned subsidiaries were voluntarily terminated. Under the Separation Agreement, the Company paid
Mr. Binninger $53,958 of a total $107,917 total severance pay as provided for in his Employment
Agreement. The remaining $53,959 of severance pay will be paid when and as Company cash assets
allow for such payment and in all events no later than March 5, 2010. Also by the Separation
Agreement, Mr. Binninger and the Company released and discharged each other from all known and
contingent liabilities and obligation. The Company retired stock options held by Mr. Binninger for
nominal consideration. Mr. Binninger will continue to serve as a director of the Company.
The
Company and Acaso Investments, LLC are entering into an Agreement Re: Termination
of Lease pursuant to which the parties terminated the Company's Lease dated June 22, 2007
respecting the entire premises at 1070 Flynn Road in Camarillo, California (the "Flynn Road
Premises") effective as of March 31, 2009. The Company will allow Acaso to apply the security
deposit to satisfy its March rent obligation and to retain certain office furniture and equipment
in consideration for a release of all future rental obligations. Asorco
will buy other office equipment for
$10,000.
John Philpott, the continuing officer of the Company, has arranged with Acaso to maintain an office
at the Flynn Road Premises for himself and will use that office as the Company's headquarters at no
cost to the Company for the term of his Employment Agreement summarized in Item 5.02 below.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers
As discussed under Item 1.02 above, as of April 15, 2009, the Company effected a Separation
Agreement with G.A. Ben Binninger, Chief Executive Officer of the Company, pursuant to which his
Employment Agreement dated December 1, 2007 and his employment with the Company and its wholly
owned subsidiaries were terminated.
On April 23, 2009, the Company elected John Philpott, Chief Financial Officer of the Company, as
the Chief Executive Officer of the Company. The Company and Mr. Philpott entered into an
Employment Agreement dated April 23, 2009 that replaces the Employment Agreement between the
Company and Mr. Philpott dated April 30, 2008 and which was scheduled to expire on April 30, 2009.
Mr. Philpott will report to the Board of Directors of the Company. He will not be required to
dedicate his full time or attention to the business of the Company. Rather, his primary
responsibilities will be to attend to the sale of the remaining equipment and inventory owned by
the Company, evaluating acquisition and merger opportunities, and attending to the Company's
periodic reporting requirements. Mr. Philpott will provide his own office space, which shall serve
as the Company's headquarters. The Company will pay Mr. Philpott a salary of $5,000 per month.
Mr. Philpott will have the opportunity to earn a performance bonus of between $1,000 and $50,000
depending upon his achieving target performance goals to be
established by the Board of Directors. The Employment Agreement is scheduled to terminate on May
31, 2010. As an inducement for Mr. Philpott accepting the Chief Executive Officer position and
waiving his rights under his April 30, 2008 Employment Agreement, the Company will pay Mr. Philpott
an inducement payment of $252,800, of which $126,400 is to be paid on or before April 30, 2009 and
the balance will be paid in installments when and as the Company has cash resources available to
make payments and in all events on or before March 5, 2010. The Company has also released its
rights to repurchase 75,000 shares of Company common stock previously issued to Mr. Philpott.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number
99.1
Separation Agreement dated as of April 15, 2009 by and among Kreido Biofuels, Inc., Kreido Laboratories and G.A. Ben Binninger.
99.2
Employment Agreement dated April 23, 2009 by and among Kreido
Biofuels, Inc. Kreido Laboratories and John Philpott.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Information included in this Form 8-K may contain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). This information may involve
known and unknown risks, uncertainties and other factors which may cause the Company's actual
results, performance or achievements to be materially different from future results, performance or
achievements expressed or implied by any forward-looking statements. Forward-looking statements,
which involve assumptions and describe the Company's future plans, strategies and expectations, are
generally identifiable by use of the words "may," "will," "should," "expect," "anticipate,"
"estimate," "believe," "intend" or "project" or the negative of these words or other variations on
these words or comparable terminology. These forward-looking statements are based on assumptions
that may be incorrect, and there can be no assurance that any projections included in these
forward-looking statements will come to pass. The Company's actual results could differ materially
from those expressed or implied by the forward-looking statements as a result of various factors.
Except as required by applicable laws, the Company undertakes no obligation to update publicly any
forward-looking statements for any reason, even if new information becomes available or other
events occur in the future.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated:  April 24, 2009
KREIDO BIOFUELS, INC.
By:
/s/ John Philpott
Name:
John Philpott
Its:
Chief Executive Officer